The Delhi High Court has dismissed AbbVie’s appeal regarding the refusal of their patent application for an anti-cMet antibody-drug conjugate. The court found the proposed amendments exceeded permissible scope under the Indian Patents Act.
Read more about AbbVie’s Patent Refusal Upheld over Impermissible Shift from Treatment to Product ClaimsTag: method of treatment
Method of producing ‘protein enriched blood serum’ is not a method of treatment under Section 3(i), says the Delhi High Court
The Delhi High Court ruled that a method of producing protein enriched blood serum is not a method of treatment under Section 3(i) of the Patents Act. The Court set aside the refusal and directed the Patent Office to reconsider the application after a fresh hearing.
Read more about Method of producing ‘protein enriched blood serum’ is not a method of treatment under Section 3(i), says the Delhi High CourtSomething More About Swiss Type Claims
This post explores the rationale, development and eventual redundancy of Swiss type claims in patent law. It analyses legal changes in Europe and India regarding second medical use, absolute novelty and recent judicial clarifications.
Read more about Something More About Swiss Type Claims